IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events [Yahoo! Finance]
IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma [Yahoo! Finance]
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)